Tibet Rhodiola Pharmaceutical Holding Co (600211) — Cash Flow Reinvestment Rate
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Reinvestment Rate of 0.07x as of December 2025, reinvesting CN¥20.26 Million (capex CN¥4.98 Million plus investments CN¥15.27 Million) from operating cash flow of CN¥297.86 Million. Check Tibet Rhodiola Pharmaceutical Holding Co (600211) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Explore 600211 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year capital reinvestment analysis for Tibet Rhodiola Pharmaceutical Holding Co. For live market cap and broader valuation context, see 600211 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥751.90 Million | CN¥1.03 Billion | CN¥15.96 Million | ▲ +70.7% |
| 2024 | 0.43x | CN¥426.90 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ -45.6% |
| 2023 | 0.79x | CN¥853.57 Million | CN¥1.08 Billion | CN¥21.69 Million | ▲ +15.1% |
| 2022 | 0.69x | CN¥573.65 Million | CN¥837.38 Million | CN¥101.96 Million | ▼ -67.0% |
| 2021 | 2.08x | CN¥760.55 Million | CN¥366.53 Million | CN¥425.58 Million | ▲ +77.2% |
| 2020 | 1.17x | CN¥501.29 Million | CN¥428.17 Million | CN¥221.29 Million | ▲ +150.3% |
| 2019 | 0.47x | CN¥229.00 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -33.5% |
| 2018 | 0.70x | CN¥203.37 Million | CN¥289.22 Million | CN¥23.37 Million | ▼ -90.5% |
| 2017 | 7.41x | CN¥677.98 Million | CN¥91.46 Million | CN¥607.98 Million | ▲ +446.0% |
| 2016 | 1.36x | CN¥339.72 Million | CN¥250.21 Million | CN¥9.64 Million | ▼ -41.8% |
| 2015 | 2.33x | CN¥312.46 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +1809.4% |
| 2013 | 0.12x | CN¥34.12 Million | CN¥279.22 Million | CN¥34.12 Million | ▲ +55.4% |
| 2012 | 0.08x | CN¥4.42 Million | CN¥56.20 Million | CN¥4.42 Million | ▼ -58.9% |
| 2011 | 0.19x | CN¥2.31 Million | CN¥12.09 Million | CN¥2.31 Million | ▼ -85.9% |
| 2010 | 1.36x | CN¥2.58 Million | CN¥1.90 Million | CN¥2.58 Million | ▲ +555.4% |
| 2009 | 0.21x | CN¥3.70 Million | CN¥17.88 Million | CN¥3.70 Million | ▼ -7.5% |
| 2008 | 0.22x | CN¥4.80 Million | CN¥21.46 Million | CN¥4.80 Million | ▼ -52.7% |
| 2006 | 0.47x | CN¥15.90 Million | CN¥33.63 Million | CN¥15.90 Million | ▲ +26.5% |
| 2005 | 0.37x | CN¥7.07 Million | CN¥18.92 Million | CN¥7.07 Million | ▼ -42.4% |
| 2004 | 0.65x | CN¥17.45 Million | CN¥26.90 Million | CN¥17.45 Million | ▲ +33.8% |
| 2003 | 0.48x | CN¥22.88 Million | CN¥47.20 Million | CN¥22.88 Million | ▼ -84.4% |
| 2002 | 3.11x | CN¥102.14 Million | CN¥32.85 Million | CN¥102.14 Million | ▼ -39.7% |
| 2001 | 5.15x | CN¥79.72 Million | CN¥15.47 Million | CN¥79.72 Million | ▼ -10.6% |
| 2000 | 5.76x | CN¥118.45 Million | CN¥20.55 Million | CN¥118.45 Million | ▼ -79.5% |
| 1999 | 28.15x | CN¥63.25 Million | CN¥2.25 Million | CN¥63.25 Million | — |